A new study published in The Journal of Pediatrics suggests that infant colic may serve as an early clinical marker for increased risk of food allergies later in childhood and adolescence. Researchers followed a cohort of 1,263 children from the “Project Viva” pre-birth study, tracking them from infancy through mid-adolescence. The findings indicate that children who experienced colic—defined as unsoothable crying accompanied by signs of abdominal distress—were significantly more likely to develop food allergies than those who did not. In contrast, “excessive crying” without physical distress showed no such association.
The biological framework for these findings positions colic as a disorder of gut-brain interaction (DGBI). The authors suggest that infant colic may reflect underlying gastrointestinal inflammation and immune dysregulation. These processes are associated with increased gut permeability and microbial imbalance, both of which have been linked to allergic disease. As a result, the researchers argue that it may be important to consider colic not simply as a transient developmental phase, but as a potential early marker of inflammatory states.
Statistical analysis revealed that infants with colic had a 70% higher likelihood of developing any food allergy in early childhood (13% vs. 8%; OR: 1.7). These risks became more pronounced for specific allergens over time. By early adolescence, children with a history of colic had 2.1 times the odds of peanut allergy and 2.6 times the odds of tree nut allergy. These elevated risks persisted into mid-adolescence, where the odds of peanut allergy were more than three times higher (OR: 3.3).
To strengthen the parent-reported findings, the study examined biomarkers in a subset of participants. Of the original cohort, 286 children had IgE data available, including 242 with both IgE measurements and infant colic/crying data. The results supported the observational findings: children with a history of colic had approximately 2.5 times the odds of IgE sensitization to peanut in early childhood. This physiological evidence reinforces the association between colic and immune system activity.
One of the study’s primary goals was to distinguish between general fussiness and true colic. While about 10% of the sample was categorized as having “excessive crying” without abdominal symptoms, this group showed no increased risk for food allergy or other atopic conditions. This distinction is clinically relevant, as the researchers note that colic and excessive crying are likely related but distinct phenomena that should be differentiated in both research and practice.
The researchers emphasize that these findings may help reframe how infant distress is interpreted. Rather than dismissing colic as a benign, self-resolving condition, it may offer an early signal of increased atopic risk. Identifying such infants could support earlier implementation of established prevention strategies, including the timely and consistent introduction of allergenic foods such as peanut.
Ultimately, the study concludes that parental reports of colic may provide useful clinical insight. By recognizing colic as a potential early-life marker of allergy risk, healthcare providers may be better positioned to identify children who could benefit from closer monitoring and preventive approaches. The authors suggest that infant colic may represent an additional tool for early risk stratification, while emphasizing the need for further research to confirm these findings and guide clinical application.
